Skip to main content
. 2017 Sep 1;10(9):10127–10133.

Figure 2.

Figure 2

MiR-181a is upregulated in cisplatin resistant prostate cancer cells. A. The cell viabilities were assayed and shown for parental PC3 and cisplatin resistant cells. B. The expressions of miR-181a was assayed and shown in parental PC3 and cisplatin resistant cells. *, P < 0.05; **, P < 0.01.